160 related articles for article (PubMed ID: 32953798)
21. Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing.
Deng J; Weng X; Ye J; Zhou D; Liu Y; Zhao K
Front Genet; 2019; 10():47. PubMed ID: 30833958
[No Abstract] [Full Text] [Related]
22. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
23. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
24. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy.
Ma H; Zheng S; Zhang X; Gong T; Lv X; Fu S; Zhang S; Yin X; Hao J; Shan C; Huang S
Cell Death Dis; 2019 Feb; 10(2):136. PubMed ID: 30755598
[TBL] [Abstract][Full Text] [Related]
25. Familial Esophageal Squamous Cell Carcinoma with damaging rare/germline mutations in KCNJ12/KCNJ18 and GPRIN2 genes.
Khalilipour N; Baranova A; Jebelli A; Heravi-Moussavi A; Bruskin S; Abbaszadegan MR
Cancer Genet; 2018 Feb; 221():46-52. PubMed ID: 29405996
[TBL] [Abstract][Full Text] [Related]
26. Identification of genomic alterations in oesophageal squamous cell cancer.
Song Y; Li L; Ou Y; Gao Z; Li E; Li X; Zhang W; Wang J; Xu L; Zhou Y; Ma X; Liu L; Zhao Z; Huang X; Fan J; Dong L; Chen G; Ma L; Yang J; Chen L; He M; Li M; Zhuang X; Huang K; Qiu K; Yin G; Guo G; Feng Q; Chen P; Wu Z; Wu J; Ma L; Zhao J; Luo L; Fu M; Xu B; Chen B; Li Y; Tong T; Wang M; Liu Z; Lin D; Zhang X; Yang H; Wang J; Zhan Q
Nature; 2014 May; 509(7498):91-5. PubMed ID: 24670651
[TBL] [Abstract][Full Text] [Related]
27. Comparative Genomic Analysis Reveals Genetic Variations in Multiple Primary Esophageal Squamous Cell Carcinoma of Chinese Population.
Liang J; Wang Y; Cai L; Liu J; Yan J; Chen X; Wu X; Chen Q
Front Oncol; 2022; 12():868301. PubMed ID: 35515115
[TBL] [Abstract][Full Text] [Related]
28. Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulation.
Cao Y; Gao A; Li X; Min H; He C; Sun X; Ding WQ; Zhou J
Cancer Med; 2021 May; 10(9):3101-3112. PubMed ID: 33787085
[TBL] [Abstract][Full Text] [Related]
29. LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy.
Chen W; Zhang Y; Wang H; Pan T; Zhang Y; Li C
J Cell Biochem; 2019 Sep; 120(9):14562-14572. PubMed ID: 31017716
[TBL] [Abstract][Full Text] [Related]
30. Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma.
Cao W; Wu W; Yan M; Tian F; Ma C; Zhang Q; Li X; Han P; Liu Z; Gu J; Biddle FG
Oncogenesis; 2015 Nov; 4(11):e175. PubMed ID: 26619400
[TBL] [Abstract][Full Text] [Related]
31. Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
Lacerda CF; Cruvinel-Carloni A; de Oliveira AT; Scapulatempo-Neto C; López RV; Crema E; Adad SJ; Rodrigues MA; Henry MA; Guimarães DP; Reis RM
Dis Esophagus; 2017 Apr; 30(4):1-9. PubMed ID: 28375484
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
33. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
[TBL] [Abstract][Full Text] [Related]
34. Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery
Zeng Y; Yu W; Liu Q; Yu WW; Zhu ZF; Zhao WX; Liu J; Wang JM; Fu XL; Liu Y; Cai XW
World J Gastrointest Oncol; 2019 Dec; 11(12):1172-1181. PubMed ID: 31908722
[TBL] [Abstract][Full Text] [Related]
35. Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma.
Dong Q; Fu L; Zhao Y; Liu Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Aug; 8(33):55135-55146. PubMed ID: 28903408
[TBL] [Abstract][Full Text] [Related]
36. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
38. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
Wang Z; Zhang J; Li M; Kong L; Yu J
Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
[TBL] [Abstract][Full Text] [Related]
39. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
40. mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.
Luo J; Wang W; Tang Y; Zhou D; Gao Y; Zhang Q; Zhou X; Zhu H; Xing L; Yu J
J Cancer; 2017; 8(4):646-656. PubMed ID: 28367244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
